InvestorsHub Logo
Followers 211
Posts 32338
Boards Moderated 1
Alias Born 06/30/2009

Re: KMBJN post# 338319

Wednesday, 12/30/2020 7:48:05 PM

Wednesday, December 30, 2020 7:48:05 PM

Post# of 403583
"What makes you question whether or not remdesivir will be used?"
Just the lack of recent mention by the Company with a pinch of trial size on the side. Remember, I speak from a position of clinical trial ignorance.

"Do you think that it would be ethical to withold a standard of care for an unproven drug like brilacidin?"
Probably not.

"Why do you feel this way?"
Why do I feel what way?


"our trial is in addition to standard of care"
For you that apparently goes without saying. I need to be told. The Company's description doesn't include it but I guess you're telling me it's assumed.
"The randomized, double-blind, placebo-controlled, multi-center study is anticipated to enroll 120 hospitalized patients with COVID-19."

Just a question....no need to be offended.


“I have had a wonderful time but this wasn't it.”
..........Groucho

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News